Status In progress
Process TAG

Timeline

Key events during the development of the guidance:

Date Update
11 March 2019 In progress, As you will be aware, the Department for Health and Social Care has asked NICE to carry out a Single Technology Appraisal of mogamulizumab for previously treated adult T-cell leukaemia-lymphoma. Following on from advice received from the company the timelines for this appraisal are to be aligned with the latest regulatory expectations and further information regarding the scheduling of this appraisal will be available in due course.

For further information on how we develop guidance, please see our page about NICE technology appraisal guidance